
浏览全部资源
扫码关注微信
纸质出版日期:2011
移动端阅览
唐旭东, 刘锋, 李柳, 等. 补肾中药联合ATG或ALG治疗重型再生障碍性贫血预后因素分析[J]. 中国实验方剂学杂志, 2011,17(8):250-254.
TANG Xu-dong, LIU Feng, LI Liu, et al. Analysis of Prognostic Factors for Treatment of Severe Aplastic Anemia by Herbs of Nourishing Kidney Combined with ATG or ALG[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(8): 250-254.
唐旭东, 刘锋, 李柳, 等. 补肾中药联合ATG或ALG治疗重型再生障碍性贫血预后因素分析[J]. 中国实验方剂学杂志, 2011,17(8):250-254. DOI: CNKI:11-3495/R.20110303.1351.013.
TANG Xu-dong, LIU Feng, LI Liu, et al. Analysis of Prognostic Factors for Treatment of Severe Aplastic Anemia by Herbs of Nourishing Kidney Combined with ATG or ALG[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(8): 250-254. DOI: CNKI:11-3495/R.20110303.1351.013.
目的: 探讨重型再生障碍性贫血(简称重型再障)以补肾中药联合抗淋巴细胞球蛋白/抗胸腺细胞球蛋白(ALG/ATG)为主的免疫抑制剂治疗效果、影响疗效因素。 方法: 采用补肾中药联合ALG/ATG对重型再障患者进行治疗
辅以环孢菌素A、雄激素、粒细胞集落刺激因子等。 结果: ①可评价的71例重型再障患者中(随访1年以上)基本治愈30例(42.3%)
缓解11例(15.5%)
明显进步18例(25.4%)
无效12例(16.9%)
总有效率为83.1%。②新诊断重型再障患者的中性粒细胞绝对值高于0.2×109/L时疗效较好(P=0.0001)
网织红细胞绝对值高于10×109/L时疗效较好(P=0.001)。但性别(P=0.320)、年龄(P=0.563)、病程(P=0.334)、血小板(P=0.621)、骨髓淋巴细胞(P=0.632)与重型再障疗效无明显关系。③通过Kaplan-Meier过程对可能影响重型再障患者生存期的因素进行多因素分析
发现年龄(P=0.026)大于60岁的患者生存期明显缩短
但中性粒细胞计数(P=0.288)、网织红细胞计数(P=0.205)、血小板计数(P=0.917)、骨髓的淋巴细胞比例(P=0.914)、发病至使用ATG/ALG的时间(P=0.093)对生存期的影响无统计学意义。 结论: 应用补肾中药联合ATG/ALG治疗重型再障
发病时中性粒细胞绝对值>0.2×109/L、网织红细胞绝对值高于10×109/L似可作为预测治疗有效指标
年龄大于60岁的患者生存期短
预后差。
Objective: To analyze the effectiveness and prognostic factors of antithymus globulin (ATG)/antilymphocyte globulin (ALG) together with herbs of nourishing the kidney in treatment of severe aplastic anemia (SAA). Method: Clinical data of 71 cases with severe aplastic anemia who received ATG/ALD treatment from 1992 to 2009 were analyzed retrospectively. Result: In the 71 patients
30 were nearly cured (42.3%)
11 were relieved (15.5%)
18 were improved (25.4%) and 12 were invalid (16.9%)
The overall effective rate was 83.1%. Among all the factors
we found that neutrophil counts (ANC) more than 0.2×109/L(P=0.0001)and the reticulocyte more than 10×109/L (P=0.001)indicated a higher remission rate
while sex (P=0.320)
age (P=0.563)
course of disease (P=0.334)
platelet count (P=0.621)
the percentage of lymphocyte in bone marrow slides less than 60% (P=0.632) had no relation with treatment results. And another research on survival rate found that patients with age over 60 had shorter life span than their counterparts. However
ANC (P=0.288)
reticulocyte count (P=0.205)
platelet count (P=0.917)
the percentage of lymphocyte in bone marrow slides (P=0.914)
the course of disease before use ATG/ALG (P=0.093) were not related with survival. Conclusion: ATG/ALG together with Chinese herbs in treatment of severe aplastic anemia was valid and safe
which could also improve clinical curative effect and increase patients’ survival rate. ANC more than 0.2×109/L and the reticulocyte more than 10×109/L would be prognostic factors for efficiency in SAA.
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621